Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTenax Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.99 | -$1.99 | -$1.99 |
| Q2 2024 | 1 | -$1.37 | -$1.37 | -$1.37 |
| Q3 2024 | 3 | -$1.02 | -$0.12 | -$0.42 |
| Q1 2025 | 2 | -$1.22 | -$0.13 | -$0.68 |
| Q2 2025 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q3 2025 | 1 | -$0.91 | -$0.91 | -$0.91 |
| Q4 2025 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q1 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q2 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q3 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
Tenax Therapeutics, Inc. Earnings Date And Information
Tenax Therapeutics, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-1.83 earnings per share for the quarter, topping analysts' consensus estimates of $-1.99 by $0.16. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tenax Therapeutics, Inc. has generated $-31 earnings per share over the last year ($-31.04 diluted earnings per share) and currently has a price-to-earnings ratio of -18.72. Tenax Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Tenax Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.19 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$1.99 | -$1.83 | 0.16 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$2.40 | $3.12 | 5.52 | $0 | |
| 03/28/2024 | Q4 2023 | -$8.14 | -$10.81 | -2.67 | $5,790 | |
| 11/13/2023 | Q3 2023 | -$7.20 | -$6.61 | 0.59 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.10 | -$4.00 | -3.9 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.37 | -$37.44 | -37.07 | $0 | |
| 03/30/2023 | Q4 2022 | -$2.28 | -$101.79 | -99.51 | $0 | |
| 11/10/2022 | Q3 2022 | -$176.00 | -$531.76 | -355.76 | $0 | |
| 08/11/2022 | Q2 2022 | -$144.00 | -$544.87 | -400.87 | $0 | |
| 05/16/2022 | Q1 2022 | -$518.07 | $0 | |||
| 03/29/2022 | Q4 2021 | -$214.04 | $0 | |||
| 11/15/2021 | Q3 2021 | -$241.18 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.13 | -$159.56 | -159.43 | $0 | |
| 05/17/2021 | Q1 2021 | -$336.00 | -$2,618.03 | -2282.03 | $0 | |
| 03/31/2021 | Q4 2020 | -$288.00 | -$282.98 | 5.02 | $0 | |
| 11/16/2020 | Q3 2020 | -$208.00 | -$285.88 | -77.88 | $0 | |
| 08/14/2020 | Q2 2020 | -$367.75 | $0 | |||
| 05/15/2020 | Q1 2020 | -$0.19 | -$609.14 | -608.95 | $0 | |
| 03/30/2020 | Q4 2019 | -$0.60 | -$8.27 | -7.67 | $0 |
Tenax Therapeutics, Inc. Earnings: FAQ's
When is Tenax Therapeutics, Inc.'s earnings date?
Tenax Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
Did Tenax Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Tenax Therapeutics, Inc. (:TENX) reported $-1.83 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.99 by $0.16.
How can I listen to Tenax Therapeutics, Inc.'s earnings conference
call?
The conference call for Tenax Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Tenax Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Tenax Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Tenax Therapeutics, Inc. generate each year?
Tenax Therapeutics, Inc. (:TENX) has a recorded net income of $0. Tenax Therapeutics, Inc. has generated $-31.09 earnings per share over the last four quarters.
What is Tenax Therapeutics, Inc.'s price-to-earnings ratio?
Tenax Therapeutics, Inc. (:TENX) has a price-to-earnings ratio of -18.72 and price/earnings-to-growth ratio is -0.44.